Literature DB >> 22153071

An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis.

Maria Hatziapostolou1, Christos Polytarchou, Eleni Aggelidou, Alexandra Drakaki, George A Poultsides, Savina A Jaeger, Hisanobu Ogata, Michael Karin, Kevin Struhl, Margarita Hadzopoulou-Cladaras, Dimitrios Iliopoulos.   

Abstract

Hepatocyte nuclear factor 4α (HNF4α) is essential for liver development and hepatocyte function. Here, we show that transient inhibition of HNF4α initiates hepatocellular transformation through a microRNA-inflammatory feedback loop circuit consisting of miR-124, IL6R, STAT3, miR-24, and miR-629. Moreover, we show that, once this circuit is activated, it maintains suppression of HNF4α and sustains oncogenesis. Systemic administration of miR-124, which modulates inflammatory signaling, prevents and suppresses hepatocellular carcinogenesis by inducing tumor-specific apoptosis without toxic side effects. As we also show that this HNF4α circuit is perturbed in human hepatocellular carcinomas, our data raise the possibility that manipulation of this microRNA feedback-inflammatory loop has therapeutic potential for treating liver cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153071      PMCID: PMC3251960          DOI: 10.1016/j.cell.2011.10.043

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  48 in total

1.  Plasticity and expanding complexity of the hepatic transcription factor network during liver development.

Authors:  Irene Kyrmizi; Pantelis Hatzis; Nitsa Katrakili; Francois Tronche; Frank J Gonzalez; Iannis Talianidis
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

2.  Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease.

Authors:  Sung-Hoon Ahn; Yatrik M Shah; Junko Inoue; Keiichirou Morimura; Insook Kim; Sunhee Yim; Gilles Lambert; Reiko Kurotani; Kunio Nagashima; Frank J Gonzalez; Yusuke Inoue
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

3.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

4.  Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.

Authors:  Runqiu Jiang; Zhongming Tan; Lei Deng; Yun Chen; Yongxiang Xia; Yun Gao; Xuehao Wang; Beicheng Sun
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

5.  miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.

Authors:  Christine Esau; Scott Davis; Susan F Murray; Xing Xian Yu; Sanjay K Pandey; Michael Pear; Lynnetta Watts; Sheri L Booten; Mark Graham; Robert McKay; Amuthakannan Subramaniam; Stephanie Propp; Bridget A Lollo; Susan Freier; C Frank Bennett; Sanjay Bhanot; Brett P Monia
Journal:  Cell Metab       Date:  2006-02       Impact factor: 27.287

6.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells.

Authors:  Amaia Lujambio; Santiago Ropero; Esteban Ballestar; Mario F Fraga; Celia Cerrato; Fernando Setién; Sara Casado; Ana Suarez-Gauthier; Montserrat Sanchez-Cespedes; Anna Git; Anna Gitt; Inmaculada Spiteri; Partha P Das; Carlos Caldas; Eric Miska; Manel Esteller
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

7.  Application of comparative functional genomics to identify best-fit mouse models to study human cancer.

Authors:  Ju-Seog Lee; In-Sun Chu; Arsen Mikaelyan; Diego F Calvisi; Jeonghoon Heo; Janardan K Reddy; Snorri S Thorgeirsson
Journal:  Nat Genet       Date:  2004-11-21       Impact factor: 38.330

Review 8.  Genomics and signaling pathways in hepatocellular carcinoma.

Authors:  Augusto Villanueva; Philippa Newell; Derek Y Chiang; Scott L Friedman; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2007-02       Impact factor: 6.115

9.  Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

Authors:  Diego F Calvisi; Sara Ladu; Alexis Gorden; Miriam Farina; Elizabeth A Conner; Ju-Seog Lee; Valentina M Factor; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 10.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

View more
  230 in total

Review 1.  MicroRNAs in liver disease.

Authors:  Xin Wei Wang; Niels H H Heegaard; Henrik Orum
Journal:  Gastroenterology       Date:  2012-04-11       Impact factor: 22.682

2.  HNF4α: a new biomarker in colon cancer?

Authors:  Karthikeyani Chellappa; Graham R Robertson; Frances M Sladek
Journal:  Biomark Med       Date:  2012-06       Impact factor: 2.851

3.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

4.  Developmental Stage-Specific Hepatocytes Induce Maturation of HepG2 Cells by Rebuilding the Regulatory Circuit.

Authors:  Yanning Li; Demei Liu; Yanhong Zong; Jinsheng Qi; Bin Li; Kun Liu; Hui Xiao
Journal:  Mol Med       Date:  2015-04-14       Impact factor: 6.354

5.  Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.

Authors:  T Palumbo; F R Faucz; M Azevedo; P Xekouki; D Iliopoulos; C A Stratakis
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

6.  Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p.

Authors:  Douglas F Dluzen; Dongxiao Sun; Anna C Salzberg; Nate Jones; Ryan T Bushey; Gavin P Robertson; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2014-01-07       Impact factor: 4.030

7.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

8.  Mir-24 regulates hepatocyte apoptosis via BIM during acute liver failure.

Authors:  Zhiwen Feng; Zhi Li; Deming Zhu; Wei Ling; Lei Zheng; Liyong Pu; Lianbao Kong
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

9.  miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3.

Authors:  Yunyun Li; Zhongzu Zhang; Xiuxia Liu; Tingting Huang; Wenfeng He; Yang Shen; Xin Liu; Kui Hong; Qing Cao
Journal:  Mol Cell Biochem       Date:  2013-11-28       Impact factor: 3.396

10.  microRNA Regulation and Its Consequences in Cancer.

Authors:  Sonya Parpart; Xin Wei Wang
Journal:  Curr Pathobiol Rep       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.